Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1304 clinical trials
Effectiveness of Relaxation Techniques

The study aims to assess the validity of a relaxation app. This will be accomplished by obtaining self-report measures about mood and respiratory symptoms. We hypothesize that self-report in the relaxation app condition will be different from that of the relaxation only condition.

respiratory symptoms
relaxation technique
  • 0 views
  • 19 Feb, 2024
Study to Assess Disease Activity and Biomarkers in Minority Participants With Relapsing Multiple Sclerosis (RMS) Before and During Treatment With Ocrelizumab

Participants will be assessed for disease activity and biomarkers of neuronal damage at baseline and during treatment with ocrelizumab.

  • 0 views
  • 19 Feb, 2024
Less Infections for the Diabetic Foot  

After eventual surgical debridement (not amputation), patients will be randomized to receive 1 of 2 targeted antibiotic regimens, in the ratio 1:1. For diabetic toe osteomyelitis, the patients will be randomized between a 3 and a 6 week's arm, for soft tissue infections between 10 and 20 days.

debridement
diabetes
antibiotic therapy
tenotomy
osteomyelitis
  • 0 views
  • 19 Feb, 2024
  • 1 location
SBRT for Breast Cancer Oligometastases

It is preferred that the same imaging method that was used to originally detect the metastases be used in follow-up assessments. The first imaging for SBRT sites will be three months post SBRT and every three months for the first year, every 6 months for the second year, then annually.

solid tumor
breast neoplasm malignant female
sbrt
breast cancer
metastasis
  • 0 views
  • 19 Feb, 2024
A Study of Lenvatinib (MK-7902) in Pediatric Participants With Relapsed or Refractory Solid Malignancies (MK-7902-013/E7080)

The main purpose of this study is to evaluate the antitumor activity and safety of Lenvatinib (MK-7902/E7080) in children, adolescents, and young adults with relapsed or refractory solid malignancies after administration. Participants will be enrolled into initial tumor-specific cohorts which will be expanded based on observed response.

cancer treatment
pediatric
karnofsky performance status
antihypertensive agents
hair thinning
  • 0 views
  • 19 Feb, 2024
A Safety and Tolerability Study of 10XB-101 Injections in Adult Subjects With Extra Fat Under the Chin ("Double Chin")

The purpose of this research study is to find out more about an investigational drug, 10XB-101, for people with fat under their chin which they would like to remove. The Sponsor of this study thinks there may be a chance this drug could be used to dissolve, or "melt" this …

  • 0 views
  • 19 Feb, 2024
Determinants of Neonatal Anemia in Women Carrying Multiples  

Determinants of neonatal anemia will be identified. Inflammatory markers will be measured in all blood samples and related to outcomes. Stable iron isotopes will be given to a subset of women to assess maternal Fe absorption and fetal Fe uptake.

Accepts healthy volunteers
  • 0 views
  • 23 Dec, 2024
  • 2 locations
Quantifying Oxygen Utilization of Tumors Using Oxygen-Enhanced Molecular MRI

Cancer cells tend to utilize (or not utilize) oxygen differently than normal cells. By using the oxygen-enhanced molecular MRI, researchers will be able to create spatial "maps" depicting areas of abnormal oxygen utilization unique to cancer. This type of information may be useful for diagnosing new cancers, understanding various "subtypes" …

MRI
metastasis
brain tumor
cancer
brain metastases
  • 0 views
  • 19 Feb, 2024
Efficacy and Safety of SP-8203 in Patients With Ischemic Stroke Requiring rtPA

This clinical trial is designed to evaluate the efficacy and safety of the combination therapy of SP-8203 (Otaplimastat) and recombinant tissue Plasminogen Activator (rtPA) standard of care. In this clinical trial, rtPA will be injected intravenously using an infusion device. If reperfusion is not occur in spite of rtPA therapy, …

brain mri
stroke
deficit
plasminogen activator
flair
  • 0 views
  • 19 Feb, 2024
Phase 1/2 Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of SEL-302 in Pediatric Subjects With MMA (reiMMAgine)

The dose of SEL-110 in the third subject in Cohort 1 may be increased up to 0.3 mg/kg depending on results from the second subject. After assessment of safety and efficacy of Cohort 1, Cohort 2 will be started in younger children.

  • 0 views
  • 19 Feb, 2024
  • 1 location